Luzitin is a privately held company whose shareholders are the following:
Privately owned pharmaceutical company devoted to the development, manufacturing and commercialization of human medicines for the worldwide market. Over the last 13 years Bluepharma evolved from a contract manufacturing organization to a company devoted to incremental and disruptive innovation.
The inventors of Luzitin’s initial IP are scientists internationally renowned for their work in the field of photochemistry and photodynamic therapy.
Venture Capital and Private Equity firm, focusing its investments on innovative, scientific and technology-based companies as well as in companies from the more traditional sectors, with significant competitive advantages and export-oriented to global markets.